Overview

NYCEDC has selected Imprint Labs as a 2025 LifeSci NYC Expansion Fund awardee, a funding opportunity for high-growth life sciences companies interested in expanding their operations in New York City. Imprint Labs, a new nonprofit initiative, announced it has raised $15 million in philanthropic funding to advance its work to decode the body’s immune memory and uncover the causes of chronic diseases. Imprint, a Focused Research Organization (FRO) catalyzed by Convergent Research, is pioneering new technologies to identify what triggers conditions like autoimmune disease, long COVID, and neuropsychiatric disorders by decoding the historical information stored in immune cells. Imprint has received philanthropic support from Eric and Wendy Schmidt, Convergent Research, Peter Reinhart, and the New York City Economic Development Corporation (NYCEDC).